SEC
FOLD

Seven Eight Capital’s Amicus Therapeutics FOLD Stock Holding History

Seven Eight Capital’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-152,604
Closed -$1.63M – 232
2024
Q3 		$1.63M Buy
152,604
+93
+0.1% +$1.01K 0.15% 238
2024
Q2 		$1.51M Sell
152,511
-8,837
-5% -$90.7K 0.16% 218
2024
Q1 		$1.9M Buy
161,348
+20,767
+15% +$266K 0.2% 154
2023
Q4 		$1.99M Buy
140,581
+106,541
+313% +$1.21M 0.23% 125
2023
Q3 		$414K Sell
34,040
-29,538
-46% -$381K 0.05% 432
2023
Q2 		$799K Buy
63,578
+53,159
+510% +$631K 0.13% 219
2023
Q1 		$116K Buy
+10,419
New +$128K 0.02% 410
2022
Q4 		– Sell
-26,303
Closed -$275K – 488
2022
Q3 		$275K Buy
+26,303
New +$293K 0.06% 401
2022
Q2 		– Sell
-24,651
Closed -$233K – 465
2022
Q1 		$233K Sell
24,651
-3,283
-12% -$30.8K 0.03% 464
2021
Q4 		$323K Buy
27,934
+12,234
+78% +$136K 0.06% 350
2021
Q3 		$150K Buy
+15,700
New +$161K 0.01% 535
2021
Q2 		– Sell
-22,603
Closed -$522K – 626
2021
Q1 		$522K Hold
22,603
– – 0.12% 257
2020
Q4 		$522K Buy
22,603
+8,149
+56% +$167K 0.12% 260
2020
Q3 		$204K Buy
14,454
+3,700
+34% +$53.9K 0.04% 520
2020
Q2 		$162K Buy
+10,754
New +$131K 0.12% 285
2018
Q2 		– Sell
-66,755
Closed -$1M – 505
2018
Q1 		$1M Sell
66,755
-68,345
-51% -$1.04M 0.08% 225
2017
Q4 		$1.94M Buy
135,100
+19,400
+17% +$267K 0.2% 187
2017
Q3 		$1.75M Buy
115,700
+114,900
+14,363% +$1.52M 0.21% 158
2017
Q2 		$8K Buy
+800
New +$6.44K ﹤0.01% 527

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Seven Eight Capital's FOLD Position: Q4 2024 in Review

Seven Eight Capital sold out of Amicus Therapeutics (FOLD) in Q4 2024, closing a stake of 152,604 shares — an estimated $1.63M sold.

Seven Eight Capital first reported a position in FOLD in Q2 2017 and held it in 19 quarters. The position peaked at $1.99M in Q4 2023. 290 funds tracked by Wall St. Rank hold FOLD as of Q4 2024.

  • Seven Eight Capital reported no remaining Amicus Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Seven Eight Capital sold 152,604 Amicus Therapeutics shares in Q4 2024, an estimated $1.63M.
  • Seven Eight Capital first reported a position in Amicus Therapeutics in Q2 2017 and held it in 19 quarters.
  • Seven Eight Capital's Amicus Therapeutics position peaked at $1.99M in Q4 2023.
  • 290 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2024.

Based on Seven Eight Capital's 13F filing for Q4 2024.